The Need for Standardization of Antiretinal Antibody Detection and Measurement

Farzin Forooghian, Ian M. MacDonald, John R. Heckenlively, Elise Héon, Lynn K. Gordon, John J. Hooks, Barbara Detrick, Robert B. Nussenblatt

Research output: Contribution to journalArticle

Abstract

Purpose: To review the current literature on the detection and measurement of antiretinal antibodies. Design: Collaborative essay. Methods: Literature review and interpretation. Results: There is strong evidence to suggest a role for antiretinal antibodies, particularly those targeting recoverin and α-enolase, in the pathogenesis of autoimmune retinopathy (AIR). Additionally, numerous other autoantibodies have been described as putative mediators of retinal degeneration and more remain to be discovered. However, assay methods described in the literature by many laboratories for the detection of circulating antiretinal antibodies have been varied and diverse, making it difficult to interpret and compare their results. Conclusions: There is currently little standardization of laboratory methods used to detect and monitor antiretinal antibodies. To measure and monitor levels of circulating antiretinal antibodies optimally in patients with AIR, development of standardized assays with stringent internal controls is required. A multicenter collaborative and validation effort is encouraged to reach a consensus on this issue.

Original languageEnglish (US)
Pages (from-to)489-495
Number of pages7
JournalAmerican Journal of Ophthalmology
Volume146
Issue number4
DOIs
StatePublished - Oct 2008

Fingerprint

Antibodies
Recoverin
Retinal Degeneration
Phosphopyruvate Hydratase
Autoantibodies

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Forooghian, F., MacDonald, I. M., Heckenlively, J. R., Héon, E., Gordon, L. K., Hooks, J. J., ... Nussenblatt, R. B. (2008). The Need for Standardization of Antiretinal Antibody Detection and Measurement. American Journal of Ophthalmology, 146(4), 489-495. https://doi.org/10.1016/j.ajo.2008.05.046

The Need for Standardization of Antiretinal Antibody Detection and Measurement. / Forooghian, Farzin; MacDonald, Ian M.; Heckenlively, John R.; Héon, Elise; Gordon, Lynn K.; Hooks, John J.; Detrick, Barbara; Nussenblatt, Robert B.

In: American Journal of Ophthalmology, Vol. 146, No. 4, 10.2008, p. 489-495.

Research output: Contribution to journalArticle

Forooghian, F, MacDonald, IM, Heckenlively, JR, Héon, E, Gordon, LK, Hooks, JJ, Detrick, B & Nussenblatt, RB 2008, 'The Need for Standardization of Antiretinal Antibody Detection and Measurement', American Journal of Ophthalmology, vol. 146, no. 4, pp. 489-495. https://doi.org/10.1016/j.ajo.2008.05.046
Forooghian F, MacDonald IM, Heckenlively JR, Héon E, Gordon LK, Hooks JJ et al. The Need for Standardization of Antiretinal Antibody Detection and Measurement. American Journal of Ophthalmology. 2008 Oct;146(4):489-495. https://doi.org/10.1016/j.ajo.2008.05.046
Forooghian, Farzin ; MacDonald, Ian M. ; Heckenlively, John R. ; Héon, Elise ; Gordon, Lynn K. ; Hooks, John J. ; Detrick, Barbara ; Nussenblatt, Robert B. / The Need for Standardization of Antiretinal Antibody Detection and Measurement. In: American Journal of Ophthalmology. 2008 ; Vol. 146, No. 4. pp. 489-495.
@article{f38001f0906b424084df2ab6af93bf50,
title = "The Need for Standardization of Antiretinal Antibody Detection and Measurement",
abstract = "Purpose: To review the current literature on the detection and measurement of antiretinal antibodies. Design: Collaborative essay. Methods: Literature review and interpretation. Results: There is strong evidence to suggest a role for antiretinal antibodies, particularly those targeting recoverin and α-enolase, in the pathogenesis of autoimmune retinopathy (AIR). Additionally, numerous other autoantibodies have been described as putative mediators of retinal degeneration and more remain to be discovered. However, assay methods described in the literature by many laboratories for the detection of circulating antiretinal antibodies have been varied and diverse, making it difficult to interpret and compare their results. Conclusions: There is currently little standardization of laboratory methods used to detect and monitor antiretinal antibodies. To measure and monitor levels of circulating antiretinal antibodies optimally in patients with AIR, development of standardized assays with stringent internal controls is required. A multicenter collaborative and validation effort is encouraged to reach a consensus on this issue.",
author = "Farzin Forooghian and MacDonald, {Ian M.} and Heckenlively, {John R.} and Elise H{\'e}on and Gordon, {Lynn K.} and Hooks, {John J.} and Barbara Detrick and Nussenblatt, {Robert B.}",
year = "2008",
month = "10",
doi = "10.1016/j.ajo.2008.05.046",
language = "English (US)",
volume = "146",
pages = "489--495",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - The Need for Standardization of Antiretinal Antibody Detection and Measurement

AU - Forooghian, Farzin

AU - MacDonald, Ian M.

AU - Heckenlively, John R.

AU - Héon, Elise

AU - Gordon, Lynn K.

AU - Hooks, John J.

AU - Detrick, Barbara

AU - Nussenblatt, Robert B.

PY - 2008/10

Y1 - 2008/10

N2 - Purpose: To review the current literature on the detection and measurement of antiretinal antibodies. Design: Collaborative essay. Methods: Literature review and interpretation. Results: There is strong evidence to suggest a role for antiretinal antibodies, particularly those targeting recoverin and α-enolase, in the pathogenesis of autoimmune retinopathy (AIR). Additionally, numerous other autoantibodies have been described as putative mediators of retinal degeneration and more remain to be discovered. However, assay methods described in the literature by many laboratories for the detection of circulating antiretinal antibodies have been varied and diverse, making it difficult to interpret and compare their results. Conclusions: There is currently little standardization of laboratory methods used to detect and monitor antiretinal antibodies. To measure and monitor levels of circulating antiretinal antibodies optimally in patients with AIR, development of standardized assays with stringent internal controls is required. A multicenter collaborative and validation effort is encouraged to reach a consensus on this issue.

AB - Purpose: To review the current literature on the detection and measurement of antiretinal antibodies. Design: Collaborative essay. Methods: Literature review and interpretation. Results: There is strong evidence to suggest a role for antiretinal antibodies, particularly those targeting recoverin and α-enolase, in the pathogenesis of autoimmune retinopathy (AIR). Additionally, numerous other autoantibodies have been described as putative mediators of retinal degeneration and more remain to be discovered. However, assay methods described in the literature by many laboratories for the detection of circulating antiretinal antibodies have been varied and diverse, making it difficult to interpret and compare their results. Conclusions: There is currently little standardization of laboratory methods used to detect and monitor antiretinal antibodies. To measure and monitor levels of circulating antiretinal antibodies optimally in patients with AIR, development of standardized assays with stringent internal controls is required. A multicenter collaborative and validation effort is encouraged to reach a consensus on this issue.

UR - http://www.scopus.com/inward/record.url?scp=51849123587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51849123587&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2008.05.046

DO - 10.1016/j.ajo.2008.05.046

M3 - Article

VL - 146

SP - 489

EP - 495

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 4

ER -